DGX vs SNPS · P/E 22, rev $5.94B vs P/E 63, rev $7.16B
Quest Diagnostics Incorporated (DGX) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the DGX and SNPS stock pages for the full models.
Not investment advice.